annual
influenza
epidem
occasion
pandem
pose
sever
threat
human
health
host
cell
factor
requir
viral
spread
cellular
surviv
attract
target
novel
approach
antivir
intervent
cleavag
activ
influenza
viru
hemagglutinin
ha
host
cell
proteas
essenti
viral
infect
howev
unknown
proteas
activ
influenza
virus
mammal
sever
candid
identifi
cell
cultur
studi
lead
concept
influenza
virus
employ
multipl
enzym
ensur
cleavag
activ
host
show
delet
singl
haactiv
proteas
gene
mice
inhibit
spread
monobas
influenza
virus
includ
pandem
swine
influenza
viru
lung
patholog
strongli
reduc
mutant
mice
protect
weight
loss
death
impair
lung
function
also
infect
monobas
influenza
viru
bodi
weight
loss
surviv
less
sever
mutant
compar
wild
type
mice
expect
mice
protect
viral
spread
patholog
infect
multibas
influenza
viru
conclus
result
identifi
host
cell
factor
essenti
viral
spread
pathogenesi
monobas
influenza
virus
annual
influenza
epidem
unpredict
pandem
pose
sever
threat
human
health
exemplifi
estim
million
death
caus
pandem
current
therapi
target
viral
protein
neuraminidas
hamper
develop
resist
due
high
mutat
rate
viru
novel
antivir
strategi
urgent
requir
invari
host
cell
factor
essenti
viral
spread
attract
target
cleavag
influenza
viru
hemagglutinin
ha
host
cell
proteas
essenti
viral
infect
ha
protein
highli
pathogen
avian
influenza
virus
harbor
multipl
basic
amino
acid
cleavag
site
activ
furin
contrast
low
pathogen
avian
human
influenza
virus
contain
monobas
cleavag
site
ha
protein
sever
studi
show
multipl
secret
proteas
activ
human
influenza
virus
infect
cell
line
see
exampl
review
howev
analysi
cultur
human
respiratori
epithelium
demonstr
influenza
viru
cleavag
activ
cellassoci
process
evid
role
secret
proteas
obtain
subsequ
type
ii
transmembran
serin
proteas
ttsp
famili
member
membran
associ
proteas
shown
activ
ha
protein
divers
human
influenza
virus
cell
cultur
addit
found
express
human
respiratori
epithelium
posit
alpha
sialic
acid
howev
role
influenza
viru
spread
pathogenesi
infect
host
yet
studi
therefor
investig
contribut
influenza
viru
replic
pathogenesi
experiment
infect
mice
focus
analysi
virus
includ
pandem
influenza
viru
subtyp
sinc
virus
subtyp
present
circul
human
popul
studi
show
delet
knockout
mice
strongli
limit
viru
spread
lung
patholog
influenza
viru
infect
delet
also
reduc
bodi
weight
loss
mortal
infect
much
lower
degre
infect
mice
assess
role
influenza
viru
infect
vivo
use
mice
carri
delet
gene
noninfect
knockout
mice
show
phenotyp
absenc
infect
describ
previous
rtpcr
analysi
kidney
tissu
confirm
absenc
full
length
transcript
upon
intranas
infect
mice
mouseadapt
variant
wild
type
mice
lost
weight
significantli
infect
infect
mice
die
wherea
knockout
mice
exhibit
bodi
weight
loss
show
sign
diseas
fig
fig
result
obtain
infect
human
isol
pandem
viru
figur
also
infect
lethal
dose
virul
viru
isol
freiburg
variant
wildtyp
mice
die
within
seven
day
post
infect
wherea
knockout
mice
show
symptom
diseas
figur
similar
result
observ
blood
oxygen
satur
level
provid
measur
lung
function
wherea
wild
type
mice
exhibit
signific
drop
peripher
blood
oxygen
satur
peak
day
post
infect
pi
viru
mutant
mice
show
mild
chang
figur
histolog
analys
infect
lung
reveal
similar
onset
influenza
infect
day
post
infect
wild
type
mice
infect
epitheli
cell
bronchiol
figur
b
e
f
howev
day
pi
viru
spread
alveolar
region
wild
type
mice
wherea
found
bronchiol
mice
figur
g
h
respect
furthermor
infect
wild
type
mice
show
strong
increas
lung
infiltr
also
number
infect
cell
wherea
knockout
mice
much
lower
number
infiltr
cell
infect
cell
observ
figur
k
l
p
respect
thu
absenc
larg
protect
anim
viru
spread
viru
induc
pathogenesi
next
assess
protect
pathogenesi
due
reduc
viral
spread
infect
could
detect
infecti
viral
particl
lung
homozyg
wild
type
mice
howev
number
infecti
particl
close
background
day
pi
mice
markedli
reduc
day
pi
compar
wild
type
mice
figur
influenzaspecif
antibodi
readili
detect
sera
knockout
mice
figur
infect
viru
demonstr
inocul
viru
abl
infect
lung
cell
elicit
humor
immun
respons
conclus
result
show
critic
effici
spread
pathogenesi
epidem
pandem
influenza
virus
vivo
requir
ha
cleavag
mous
lung
next
sought
obtain
direct
evid
lack
proteolyt
cleavag
ha
defici
mice
bronchoalveolar
lavag
bal
infect
mice
collect
proteolyt
process
ha
precursor
protein
analyz
infect
high
dose
viru
process
well
nonprocess
protein
detect
infect
wild
type
mice
wherea
protein
found
homozyg
mutant
mice
figur
result
demonstr
essenti
effici
ha
cleavag
activ
mice
mice
also
protect
pathogenesi
infect
viru
lesser
extent
present
influenza
virus
ha
subtyp
circul
human
therefor
investig
viru
also
depend
express
function
gene
infect
low
dose
focu
form
unit
ffu
mouseadapt
viru
bodi
weight
loss
less
sever
surviv
increas
knockout
compar
wild
type
mice
figur
b
infect
higher
dose
ffu
viru
mortal
significantli
lower
mice
compar
wild
type
mice
figur
howev
signific
differ
observ
amount
infecti
particl
day
pi
figur
thu
activ
requir
process
virus
may
cleav
proteas
addit
requir
spread
pathogenesi
viru
multibas
cleavag
site
cell
cultur
dispens
cleavag
activ
virus
multibas
cleavag
site
thu
resist
knockout
mice
infect
inde
due
lack
ha
process
viru
multibas
cleavag
site
spread
effici
caus
diseas
investig
infect
mice
mouseadapt
influenza
viru
contain
multibas
ha
cleavag
site
mortal
bodi
weight
loss
infect
mice
significantli
differ
compar
wild
type
infect
mice
figur
suggest
presenc
multibas
cleavag
site
render
viral
spread
pathogenesi
independ
express
final
investig
murin
abl
activ
ha
protein
virus
coexpress
proteas
respect
ha
protein
virus
transfect
cell
facilit
ha
cleavag
virus
figur
addit
express
cell
cultur
system
allow
spread
virus
trypsinindepend
fashion
figur
contrast
spread
mouseadapt
viru
contain
multibas
cleavag
season
influenza
epidem
pandem
repres
seriou
health
threat
human
popul
resist
present
avail
antivir
drug
frequent
observ
therefor
identif
new
target
antivir
therapi
urgent
need
host
proteas
requir
process
viru
hemagglutinin
may
thu
repres
suitabl
target
intervent
report
delet
singl
host
proteas
gene
mice
protect
host
viral
spread
infect
lung
mild
pathogenesi
observ
mutant
mice
infect
viru
less
sever
pathogenesi
observ
infect
viru
thu
result
suggest
host
proteas
may
prime
target
antivir
intervent
knockout
influenza
resist
figur
essenti
spread
pathogenesi
influenza
virus
eight
eleven
week
old
femal
mice
infect
ffu
mouseadapt
ffu
b
ffu
mouseadapt
c
bodi
weight
loss
monitor
day
pi
mice
weight
loss
start
bodyweight
euthan
record
dead
weight
loss
data
repres
mean
valu
sem
note
data
surviv
mice
present
eg
infect
mice
die
infect
see
fig
bodi
weight
loss
significantli
differ
wild
type
homozyg
mutant
mice
day
pi
infect
mice
infect
mice
use
nonparametr
mann
whitney
u
test
heterozyg
homozyg
mutant
mice
infect
mice
use
mann
whitney
u
test
knockout
influenza
resist
plo
pathogen
wwwplospathogensorg
site
depend
express
thu
murin
like
human
homologu
activ
ha
cleavag
activ
influenza
viru
ha
host
cell
proteas
essenti
viral
infect
howev
natur
proteas
requir
cleavag
activ
virus
monobas
ha
cleavag
site
infect
host
organ
remain
unclear
least
eight
candid
enzym
differ
proteas
famili
suggest
base
cell
cultur
studi
lead
concept
redund
proteolyt
enzym
activ
influenza
virus
host
show
first
time
delet
singl
proteas
mice
larg
abrog
viral
spread
protect
anim
sever
patholog
death
lower
extent
influenza
viru
infect
infect
mice
viru
process
ha
precursor
protein
observ
bal
howev
initi
increas
viral
titer
measur
day
day
pi
wherea
later
time
pi
viral
titer
rapidli
decreas
initi
increas
viral
titer
expect
viru
use
infect
produc
embryon
chicken
egg
therefor
carri
activ
ha
allow
enter
cell
replic
addit
conceiv
proteas
besid
may
facilit
low
level
cleavag
allow
limit
viral
spread
rapidli
clear
antivir
immun
respons
activ
howev
cleavag
activ
altern
enzym
must
ineffici
sinc
viral
titer
infect
mice
markedli
reduc
compar
wild
type
anim
weight
loss
observ
surprisingli
viru
also
carri
monobas
cleavag
site
ha
abl
replic
mice
howev
bodi
weight
loss
mortal
significantli
reduc
knockout
mice
compar
wild
type
mice
dosedepend
manner
hand
viral
load
significantli
lower
mutant
mice
infect
ffu
amino
acid
sequenc
ha
loop
recogn
proteas
differ
ha
subtyp
figur
recent
studi
demonstr
differ
proteas
includ
hat
even
trypsin
cleav
ha
differ
subtyp
variant
vari
effici
addit
matriptas
capabl
cleav
ha
particular
subtyp
strain
minim
cleavag
observ
furthermor
kallikrein
relatedpeptidas
describ
host
proteas
capabl
cleavag
activ
viral
ha
vitro
thu
appear
process
extent
result
reduc
patholog
knockout
mice
also
proteas
abl
cleav
hemagglutinin
vivo
final
noteworthi
mutant
mice
protect
infect
viru
contain
multibas
ha
cleavag
site
activ
ubiquit
express
proteas
find
may
potenti
develop
futur
influenza
viru
therapeut
broad
spectrum
proteas
inhibitor
shown
inhibit
influenza
viru
cell
cultur
vivo
unwant
side
effect
major
concern
result
report
suggest
target
singl
proteas
may
suffici
achiev
notabl
therapeut
benefit
influenza
virus
possibl
subtyp
block
may
associ
sever
unwant
side
effect
sinc
mice
healthi
show
phenotyp
alter
absenc
infect
furthermor
inhibitor
might
exert
activ
divers
respiratori
infect
exampl
human
metapneumoviru
emerg
merscoronaviru
sarscoronaviru
also
activ
cell
cultur
might
use
proteas
support
spread
infect
host
howev
note
find
mous
model
system
requir
valid
human
infecti
viru
particl
determin
lung
homogen
viral
load
higher
infect
wild
type
mice
compar
infect
homozyg
mutant
mice
day
pi
individu
valu
mean
sem
present
detect
limit
assay
infecti
particl
per
lung
indic
blue
line
day
pi
n
n
day
pi
n
n
day
pi
n
n
figur
hemagglutinin
influenza
viru
process
knockout
mice
bal
infect
wild
type
male
mice
harvest
day
infect
ffu
viral
particl
concentr
centrifug
sucros
cushion
control
bal
noninfect
wild
type
analyz
sampl
load
undilut
first
lane
two
dilut
second
lane
third
lane
viruscontain
pellet
analyz
ha
cleavag
western
blot
load
control
strip
membran
incub
antiinfluenza
viru
antibodi
confirm
equal
amount
protein
load
respect
undilut
dilut
sampl
thorsten
wolff
robertkochinstitut
berlin
differ
virul
viru
isol
describ
origin
deriv
seal
adapt
mous
serial
passag
mous
lung
laboratori
strain
use
gener
revers
genet
use
plasmid
rescu
system
viru
figur
knockout
mice
show
reduc
bodi
weight
loss
mortal
infect
low
dose
influenza
viru
infect
eight
eleven
week
old
femal
mice
infect
ffu
mouseadapt
influenza
viru
intranas
applic
bodyweight
surviv
b
monitor
day
pi
addit
mice
found
dead
mice
weight
loss
start
bodi
weight
euthan
record
dead
homozyg
knockout
mice
lost
significantli
less
weight
wild
type
eg
p
day
p
day
use
mwu
test
mice
show
reduc
mortal
compar
wild
type
mice
although
differ
signific
use
log
rank
test
knockout
influenza
resist
stock
prepar
infect
embryon
chicken
egg
mdck
cell
describ
mutant
mice
mix
background
anim
maintain
specif
pathogen
free
condit
anim
facil
hzi
braunschweig
heterozyg
mutant
mice
interbr
wild
type
heterozyg
homozyg
mutant
mice
genotyp
pcr
analysi
use
infect
genotyp
allel
carri
use
three
primer
strategi
allow
distinguish
wild
type
yield
bp
product
knockout
yield
bp
product
allel
respect
express
plasmid
encod
human
mous
proteas
publish
earlier
previous
describ
express
plasmid
use
templat
amplif
respect
code
region
use
oligonucleotid
gggggtaccaccatgaaggcaaacctactggtcctg
gggcgctagctcagatgcatattctgcactg
result
pcr
product
insert
plasmid
pcagg
use
nhei
site
clone
ha
protein
express
plasmid
kindli
provid
prof
klenk
use
templat
amplif
code
region
use
figur
knockout
mice
show
reduc
mortal
infect
high
dose
influenza
viru
infect
eight
eleven
week
old
femal
mice
infect
ffu
mouseadapt
influenza
viru
intranas
applic
surviv
monitor
day
pi
addit
mice
found
dead
mice
weight
loss
start
bodi
weight
euthan
record
dead
infecti
viral
particl
determin
lung
homogen
b
individu
valu
mean
sem
present
detect
limit
assay
infecti
particl
per
lung
indic
blue
line
homozyg
knockout
mice
show
significantli
reduc
mortal
compar
wild
type
heterozygot
mice
p
respect
use
log
rank
test
viral
load
significantli
differ
infect
wild
type
mice
compar
infect
homozyg
mutant
mice
day
pi
knockout
influenza
resist
plo
pathogen
wwwplospathogensorg
oligonucleotid
gggaattcaccatgaaggcaatactagtagttctgc
gggctcgagttaaatacatattctacactgtagag
result
pcr
product
insert
plasmid
pcagg
use
ecori
xhoi
infect
experi
femal
mice
age
week
anesthet
intraperiton
inject
ketaminxylazin
solut
steril
nacl
mgml
ketamin
invesa
arzneimittel
gmbh
freiburg
xylazin
bayer
healthcar
leverkusen
dose
adjust
individu
bodi
weight
infect
perform
intranas
applic
viru
solut
ml
steril
phosphatebuff
salin
subsequ
surviv
bodi
weight
loss
monitor
day
pi
addit
mice
found
dead
mice
weight
loss
start
bodi
weight
euthan
record
dead
viral
load
infect
lung
determin
mdck
ii
madindarbi
canin
kidney
ii
cell
use
ffu
assay
describ
detect
limit
assay
infecti
particleslung
thu
sampl
viru
detect
data
point
set
ffulung
analysi
ha
viral
particl
bronchoalveolar
lavag
bal
wild
type
knockout
mice
infect
ffu
harvest
day
pi
centrifug
full
speed
supernat
load
sucros
cushion
concentr
viral
particl
h
full
speed
pellet
viral
particl
lyse
load
buffer
addit
mice
found
dead
mice
weight
loss
start
bodyweight
euthan
record
dead
signific
differ
observ
surviv
heterozyg
homozyg
mutant
mice
infect
use
log
rank
test
immunoblot
lysat
separ
sd
gel
electrophoresi
blot
nitrocellulos
membran
ha
detect
stain
rabbit
antibodi
sino
biolog
dilut
follow
incub
horseradish
peroxidas
hrp
coupl
antirabbit
antibodi
dianova
dilut
load
control
membran
strip
strip
buffer
trishcl
ph
sd
mm
min
wash
h
dh
stain
na
use
antiinfluenza
viru
goat
serum
millipor
dilut
follow
incub
horseradish
peroxidas
hrp
coupl
antigoat
antibodi
dianova
dilut
band
visual
use
commerci
avail
kit
ecl
prime
western
blot
detect
reagent
amersham
eight
twelv
week
old
mice
infect
intranas
ffu
amount
oxygen
satur
determin
mouseoxh
system
starr
life
scienc
corp
period
day
oxygen
measur
mice
anesthet
use
isofluran
inhal
lung
prepar
immersionfix
hour
buffer
formaldehyd
solut
ph
dehydr
seri
grade
ethanol
embed
paraffin
section
mm
cut
five
evenli
distribut
level
paraffin
block
stain
haematoxylin
eosin
immunohistochem
studi
section
stain
polyclon
primari
antibodi
influenza
virion
virostat
overnight
subsequ
tissu
section
incub
min
secondari
antibodi
rabbit
antigoatbiotin
kpl
gaithersburg
madison
usa
counterstain
haematoxylin
cell
transient
transfect
express
plasmid
encod
human
mous
control
transfect
empti
plasmid
h
post
transfect
cell
infect
either
influenza
virus
multipl
infect
moi
h
incub
viru
remov
fresh
mem
medium
supplement
bsa
mgml
tpcktrypsin
pb
ad
cell
h
pi
supernat
harvest
clear
debri
centrifug
min
rpm
store
quantif
infecti
viru
particl
focu
format
assay
ffu
describ
previous
figur
essenti
influenza
viru
pathogenesi
eight
eleven
week
old
femal
mice
infect
ffu
mouseadapt
surviv
monitor
day
pi
addit
mice
found
dead
mice
weight
loss
start
bodyweight
euthan
record
dead
knockout
mice
surviv
infect
wherea
wild
type
heterozyg
mice
die
tif
figur
surviv
mice
mount
antibodi
viral
protein
infect
influenza
viru
infect
blood
surviv
mice
collect
heart
punctur
sera
dilut
elisa
perform
use
plate
coat
ffu
viru
detect
viru
specif
igg
peroxidaselabel
antimous
igg
kpl
gaithersburg
madison
usa
use
secondari
antibodi
visual
reaction
carri
use
peroxidas
specif
substrat
absorb
nm
shown
control
sera
noninfect
mice
analyz
sera
surviv
wild
type
homozyg
mutant
mice
infect
b
analyz
day
infect
influenzaspecif
igg
antibodi
individu
valu
mean
sem
present
tif
figur
murin
activ
divers
influenza
virus
cleavag
hemagglutinin
indic
ha
protein
proteas
human
mous
transient
coexpress
cell
cell
treat
pb
trypsin
ha
cleavag
detect
western
blot
proteas
transfect
cell
infect
indic
virus
multipl
infect
presenc
absenc
trypsin
